(Q80059433)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

0 references

1 reference

title

Recent developments in cell-based immune therapy for neuroblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

1 reference

Michael R Verneris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

John E Wagner

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

2 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmune Pharmacology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

134-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells

28 December 2019

cites work

1 reference

12 December 2020

Humoral response to vaccination with interleukin-2-expressing allogeneic neuroblastoma cells after primary therapy

1 reference

12 December 2020

Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation

1 reference

12 December 2020

Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.

1 reference

12 December 2020

Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma

1 reference

12 December 2020

Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.

1 reference

12 December 2020

Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma

1 reference

12 December 2020

The function of gammadelta T cells in innate immunity

1 reference

12 December 2020

Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications

1 reference

12 December 2020

Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.

1 reference

12 December 2020

Advances in the diagnosis and treatment of neuroblastoma

1 reference

12 December 2020

Induction of proliferation and augmented cytotoxicity of gammadelta T lymphocytes by bisphosphonate clodronate

1 reference

12 December 2020

Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma

1 reference

12 December 2020

Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation.

1 reference

12 December 2020

Evidence of graft-versus-tumor effect in refractory metastatic neuroblastoma

1 reference

12 December 2020

Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients

1 reference

12 December 2020

Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma

1 reference

12 December 2020

IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma

1 reference

12 December 2020

Feasibility of high-dose interleukin-2 in heavily pretreated pediatric cancer patients

1 reference

12 December 2020

Immunological Evaluation of Pediatric Cancer Patients Receiving Recombinant Interleukin-2 in a Phase I Trial

1 reference

12 December 2020

Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells

1 reference

12 December 2020

A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study

1 reference

12 December 2020

Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.

1 reference

12 December 2020

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity

1 reference

12 December 2020

A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer.

1 reference

12 December 2020

Gammadelta T cells for immune therapy of patients with lymphoid malignancies

1 reference

12 December 2020

Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma

1 reference

12 December 2020

Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.

1 reference

12 December 2020

Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients

1 reference

12 December 2020

Immunogenicity of human neuroblastoma.

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

12 December 2020

1 reference

12 December 2020

Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma

1 reference

12 December 2020

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

1 reference

12 December 2020

gammadelta T cells: a new frontier for immunotherapy?

1 reference

12 December 2020

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

1 reference

12 December 2020

Genetic engineering of cytolytic T lymphocytes for adoptive T-cell therapy of neuroblastoma

1 reference

12 December 2020

Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation

1 reference

12 December 2020

Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma

1 reference

12 December 2020